Indications for skin-sparing mastectomy are BRCA1/2 mutation, intraepithelial neoplasia (DIN or LIN), particularly when the lesion is extensive, multicentric or recurrent, and early-stage breast cancer for which breast-conserving therapy is not suitable [63]. Here, BRCA1 is linked to breast carcinoma.